Open Access Open Access  Restricted Access Subscription Access

New Spectrophotometric Methods for the Quantification of an Anti-Peptic Ulcer Drug in Bulk and Tablets

Gummadi Sowjanya, Meghasesha Myneni

Abstract


Two simple, economical and reproducible fundamental and derivative UV spectrophotometric methods were developed and validated for determination of Famotidine in bulk and dosage form. Famotidine showed maximum absorption at 281 nm in phosphate buffer pH 7.5 while it has 282 nm as its absorption maxima in borate buffer pH 9.0. The linearity was determined in the concentration range of 30-80 μg/mL (r2 as 0.9993 & 0.9987) and 10-60 µg/mL (r2 as 0.9991 & 0.9995) for the fundamental and derivative methods in phosphate and borate buffers. The developed methods were validated as per ICH guidelines. Recovery studies gave satisfactory results indicating that none of the major additives/excipients interfered with the assay method. This method may be useful for routine laboratory analysis of famotidine.

Full Text:

PDF

References


Indian Pharmacopoeia (2014), Government of India, Ministry of Health & Family Welfare, The Indian Pharmacopoeia Commission, Ghaziabad, Volume 2.

Li H, Xuan J (1993), “UV-spectrophotometry of famotidine tablets”, Zhongguo Yiyao gangye Zazhi, Volume 24, pp. 319−321.

Mohite MT, Shet SN, Shaikh S, Vaidya VR, Karodi RS (2010), “Analytical method development of famotidine USP in bulk and single component formulation”, IJRAP, Volume 1, Issue 2, pp. 475−479.

Okram ZD, Kanakapura B, Pavagada JR et al. (2011), “Simple and sensitive UV spectrophotometric methods for determination of famotidine in tablet formulations”, Farmacia, Volume 59, Issue 5, pp. 647−657.

Yogita BW, Dipak DP, Joshi NS, Bari SB (2013), “Development and validation of difference spectrophotometric method for the estimation of famotidine in bulk and pharmaceutical dosage form”, Int. J. Drug Dev. & Res., Volume 5, Issue 2, pp. 272−277.

Erum Z, Sohail H, Hafiz Mi et al. (2014), “Development and validation of a UV spectrophotometric method for determination of famotidine in suspensions”, Fuuast J. Biol., Volume 4, Issue 1, pp. 7−12.

Safila N, Farya Z (2014), “UV spectrophotometric assay of famotidine formulations”, American Journal of Pharmacy and Pharmacology, Volume 1, Issue 3, pp. 28−31.

Vijaya Bhaskara RT, Rambabu C, Sowjanya RN et al. (2014), “Assay of famotidine in API and dosage forms by UV direct and UV derivative spectrophotometric methods”, Der Pharmacia Sinica., Volume 5, Issue 1, pp. 57−65.

Ranganath MK, Narendra RK (2014), “Method development and validation for the estimation of famotidine in pure and tablet dosage form by derivative UV spectroscopy”, Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences, Volume 4, Issue 1, pp. 17−21.

Ritesh K, Amrish C, Pawan KG (2017), “Development and validation of ultraviolet spectrophotometric method for quantitative estimation of famotidine in bulk and tablet dosage form”, Asian J Pharm Clin Res., Volume 10, Issue 8, pp. 381−385.

Agarwal YK, Shivaramachandra K, Singh GN et al. (1992), “Spectrophotometric determination of famotidine in pharmaceutical preparations”, J Pharm Biomed Anal.; Volume 10, Issue 7, pp. 521−523. https://doi.org/10.1016/0731-7085(92)80074-W

Kamath BV, Shivram K, Vangani S (1992), “Spectrophotometry determination of famotidine by charge transfer complexation”, Anal. Let., Volume 25, Issue 12, pp. 2239−2247.

Abuzuhri AZ, Shubiertah RM, Badah GM (1999), “Extractional spectrophotometric determination of famotidine in pharmaceutical formulations”, J. Pharm. Biomed. Anal., Volume 21, Issue 2, pp. 459−465.

Sastry CSP, Chintalpati R (2000), “Two simple visible spectrophotometric methods for the assay of famotidine in bulk drug form and formulation”, East Pharm., Volume 43, pp. 159−161.

Rahman N, Kashif M (2003), “Kinetic spectrophotometric determination of Famotidine in commercial dosage forms”, Analytical Sciences, Volume 19, Issue 6, pp. 907.

Rahman N, Kashif M (2003), “Application of ninhydrin to spectrophtometric determination of famotidine in drug formulation”, IL Farmaco, Volume 58, Issue 10, pp. 1045−1050. https://doi.org/10.1016/S0014-827X(03)00184-8.

Darwish IA, Hussein SA, Mohmoud AM et al. (2007), “Sensitive indirect spectrophotometric method for determination of H2-receptor antagonists in pharmaceutical formulations”, Int. J. Biomed. Sci., Volume 3, Issue 2, pp. 123−103.

Kanakapura B, Okram Z (2011), “Spectrophotometric determination of famotidine using sulphonphthalein dyes”, Química Nova., Volume 4, Issue 5, pp. 735−742. http://dx.doi.org/10.1590/S0100-40422011000500002

Walash MI, Sharaf-El-Din, MK, El-Sayed MM et al. (2009), “Spectrofluorimetric determination of famotidine in pharmaceutical preparations and biological fluids, Application to stability studies”, J Fluoresc, Volume 19, pp. 333−344.

Biffar SE, Mazzo DJ (1986), “Reversed-phase determination of famotidine, potential degradates, and preservatives in pharmaceutical formulations by high-performance liquid chromatography using silica as a stationary phase”, J. Chromatogr., Volume 363, Issue 2, pp. 243−249.

Mutaz A, Sheikh S, Hanan AN, Adnan BA (1989), “High pressure liquid chromatographic analysis and dissolution of famotidine in tablet formulation”, Anal Lett., Volume 22, Issue 11, 12, pp. 2501−2505.

Cakir B, Tosun AV, Sahin MF (1997), “Quantitative high-performance liquid chromatography analysis of Famotidine in Pharmaceutical dosage forms”, Pharmaceutical Science, Volume 3, Issue 10, pp. 493−495.

Tahboub YR, Zaater MF, Najib NM (1998), “Reversed phase liquid chromatography method for the determination of Famotidine in serum”, Quin Anal, Volume 17, pp. 117−120.

Zendelovska D, Stafilov T (2003), “High-performance liquid chromatographic determination of famotidine in human plasma using solid-phase column extraction”, J. Serb. Chem. Soc., Volume 68, Issue 11, pp. 883−892.

Helali N, Darghouth F, Monser L (2004), “RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals”, Chromatographia,; Volume 60, Issue 7, 8, pp. 455−460.

Zarghi A, Shapaati A, Foroutan SM et al. (2005), “Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column”, J. Pharm. Biomed. Anal., Volume 39, Issue 3, 4, pp. 677−680.

Helali N, Monser L (2008), “Stability indicating method for famotidine in pharmaceuticals using porous graphite column”, Journal of Serparation Sciences, Volume 31, Issue 2, pp. 276−282.

Dowling G, Gallo P, Fabbrocino S et al. (2008), “Determination of famotidine in human plasma and urine by high-performance liquid chromatography”, Food Addit. Conta., Volume 25, Issue 12, pp. 1497−1508.

Vamsi Krishna M, Madhavi G, Rama Prasad LA et al. (2010), “Impurity profiling of famotidine in bulk drugs and pharmaceutical formulations by RP-HPLC method using ion pairing agent”, Der Pharm. Lett., Volume 2, Issue 3, pp. 1−11.

Reddy TVB, Ramu G, Lakshmana Rao PV et al. (2012), “Development and validation of stability indicating reverse phase liquid chromatography method for assay of famotidine in bulk and formulations”, Rasayan J.Chem., Volume 5, Issue 2, pp. 250−255.

Campbell AN, Sherma J (2003), “Determination of famotidine in acid reduction tablets by HPTLC and video densitometry of fluorescence quenched zones”, J Liquid Chromatogr Relat Technol., Volume 26, Issue 16, pp. 2719−2722. https://doi.org/10.1081/JLC-120024542

Tzanavaras PD, Verdoukas A, Balloma T (2006), “Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis”, J. Pharm. Biomed. Anal., Volume 41, Issue 2, pp. 437−441.

Tang YH, Wang NN, Xiong XY et al. (2007), “A new sensitive flow-injection chemiluminescence method for the determination of H(2)-receptor antagonists”, J Biolumin Chemilumin,; Volume 22, Issue 4, pp. 343−348. DOI: 10.1002/bio.969

Squella JA, Valencia J, Lenus I et al. (1989), “Polarographic determination of famotidine in dosage forms”, J Assoc off Anal Chem, Volume 72, pp. 549−551.

Ayad MM, Shalaby A, Abdullatif HE et al. (2002), “Potentiometric determination of famotidine in pharmaceutical formulations”, J Pharm Biomed Anal., Volume 29, pp. 247−254.

Ibrahim WM, Sharaf-El-Din MK, El-Sayed MM (2005), “Polarographic determination of famotidine through complexation with Nickel(II) Chloride”, J Chin Chem Soc., Volume 52, pp. 927−935.

(Nov 2005), “ICH Harmonized Tripartite Guidelines, Validation of Analytical Procedures: Text and Methodology Q2 (R1)”.


Refbacks

  • There are currently no refbacks.